• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
              Advocacy & Research for Unlimited Lifespans


Drug-Induced Mitochondrial Toxicity in the Geriatric Population: Challenges and Future Directions

drug-induced mitochondrial toxicity polypharmacy aging

  • Please log in to reply
No replies to this topic
⌛⇒ support MITOMOUSE via LongeCity!

#1 Engadin

  • Guest
  • 105 posts
  • 252
  • Location:Madrid
  • NO

Posted 16 May 2019 - 06:15 PM

Published at Latest Aging Research Update



Mitochondrial function declines with age, leading to a variety of age-related diseases (metabolic, central nervous system-related, cancer, etc.) and medication usage increases with age due to the increase in diseases. Drug-induced mitochondrial toxicity has been described for many different drug classes and can lead to liver, muscle, kidney and central nervous system injury and, in rare cases, to death. Many of the most prescribed medications in the geriatric population carry mitochondrial liabilities. We have demonstrated that, over the past decade, each class of drugs that demonstrated mitochondrial toxicity contained drugs with both more and less adverse effects on mitochondria. As patient treatment is often essential, we suggest using medication(s) with the best safety profile and the avoidance of concurrent usage of multiple medications that carry mitochondrial liabilities. In addition, we also recommend lifestyle changes to further improve one’s mitochondrial function, such as weight loss, exercise and nutrition.





F U L L   T E X T :   MDPI - Biology



Also tagged with one or more of these keywords: drug-induced mitochondrial toxicity, polypharmacy, aging

0 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users